Alterations in Fas (CD 95/Apo-1) and Fas ligand (CD178) expression in acute promyelocytic leukemia during treatment with ATRA

Leukemia and Lymphoma

Volumn 45, Issue 1, 2004, Pages 55-59

  Salih, Helmut R ^a   Kiener, Peter A ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b MEDIMMUNE   (United States)

Author keywords

ATRA; Fas; Fas ligand; Promyelocytic leukemia

Indexed keywords

FAS ANTIGEN; FAS LIGAND; RETINOIC ACID;

APOPTOSIS; BLAST CELL; CELL DIFFERENTIATION; CELL INTERACTION; DATA ANALYSIS; GENE EXPRESSION; GENE MUTATION; HOST CELL; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REGULATORY MECHANISM; RETROSPECTIVE STUDY; REVIEW;

ANTIGENS, CD95; FAS LIGAND PROTEIN; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MEMBRANE GLYCOPROTEINS; TRETINOIN;

EID: 0842322921     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819031000139684     Document Type: Review

References (37)

1. Niederreither, K., Subbarayan, V., Dolle, P. and Chambon, P. (1999) "Embryonic retinoic acid synthesis is essential for early mouse post-implantation development", Nature Genetics, 21, 444-448.
2. Massaro, G.D., Massaro, D., Chan, W.Y., Clerch, L.B., Ghyselinck, N., Chambon, P., et al. (2000) "Retinoic acid receptor-beta: an endogenous inhibitor of the perinatal formation of pulmonary alveoli", Physiological Genomics, 4, 51-57.
3. Imai, T., Jiang, M., Kastner, P., Chambon, P. and Metzger, D. (2001) "Selective ablation of retinoid X receptor alpha in hepatocytes impairs their lifespan and regenerative capacity", Proceedings of the National Academy of Sciences of the United States of America, 98, 4581-4586.
4. Wan, Y.J., An, D., Cai, Y., Repa, J.J., Hung-Po, C.T., Flores, M., et al. (2000) "Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver", Molecular Cellular Biology, 20, 4436-4444.
5. Altucci, L., Rossin, A., Raffelsberger, W., Reitmair, A., Chomienne, C. and Gronemeyer, H. (2001) "Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL", Nature Medicine, 7, 680-686.
6. Dupe, V., Ghyselinck, N.B., Thomazy, V., Nagy, L., Davies, P.J., Chambon, P., et al. (1999) "Essential roles of retinoic acid signaling in interdigital apoptosis and control of BMP-7 expression in mouse autopods", Development Biology, 208, 30-43.
7. Marill, J., Idres, N., Capron, C.C., Nguyen, E. and Chabot, G.G. (2003) "Retinoic acid metabolism and mechanism of action: a review", Current Drug Metabolism, 4, 1-10.
8. Altucci, L. and Gronemeyer, H. (2001) "The promise of retinoids to fight against cancer", National Review of Cancer, 1, 181-193.
9. Collins, S.J. (2002) "The role of retinoids and retinoic acid receptors in normal hematopoiesis", Leukemia, 16, 1896-1905.
10. Piazza, F., Gurrieri, C. and Pandolfi, P.P. (2001) "The theory of APL", Oncogene, 20, 7216-7222.
11. Wang, Z.Y. and Chen, Z. (2000) "Differentiation and apoptosis induction therapy in acute promyelocytic leukaemia", Lancet Oncology, 1, 101-106.
12. Gianni, M., Ponzanelli, I., Mologni, L., Reichert, U., Rambaldi, A., Terao, M., et al. (2000) "Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases", Cell Death and Differentiation, 7, 447-460.
13. James, S.Y., Williams, M.A., Newland, A.C. and Colston, K.W. (1999) "Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D", General Pharmacology, 32, 143-154.
14. Ketley, N.J., Allen, P.D., Kelsey, S.M. and Newland, A.C. (1997) "Modulation of idarubicin-induced apoptosis in human acute myeloid leukemia blasts by all-trans retinoic acid, 1,25(OH)2 vitamin D3, and granulocyte-macrophage colony-stimulating factor", Blood, 90, 4578-4587.
15. Winzen, R., Wallach, D., Engelmann, H., Nophar, Y., Brakebusch, C., Kemper, O., et al. (1992) "Selective decrease in cell surface expression and mRNA level of the 55-kDa tumor necrosis factor receptor during differentiation of HL-60 cells into macrophage-like but not granulocyte-like cells", Journal of Immunology, 148, 3454-3460.
16. Munker, R., Koeffler, P., Haas, R. and Wilmanns, W. (2000) "Modulation of CD95 in leukemia and lymphoma cells by retinoids", European Journal Medical Research, 5, 273-276.
17. Ohashi, M., Iwase, M. and Nagumo, M. (2000) "Changes in susceptibility to Fas-mediated apoptosis during differentiation of HL-60 cells", Journal of Leukocyte Biology, 67, 374-380.
18. Robertson, K.A., Hill, D.P., Kelley, M.R., Tritt, R., Crum, B., Van Epps, S., et al. (1998) "The myeloid zinc finger gene (MZF-1) delays retinoic acid-induced apoptosis and differentiation in myeloid leukemia cells", Leukemia, 12, 690-698.
19. Dipietrantonio, A., Hsieh, T.C. and Wu, J.M. (1996) "Differential effects of retinoic acid (RA) and N-(4-hydroxyphenyl) retinamide (4-HPR) on cell growth, induction of differentiation, and changes in p34cdc2, Bcl-2, and actin expression in the human promyelocytic HL-60 leukemic cells", Biochemical and Biophysical Research Communications, 224, 837-842.
20. Rumi, C., Rutella, S., Lucia, B.M., Teofili, L., De, S.V. and Leone, G. (1997) "APO-1/Fas receptor (CD95) is non-functionally expressed in acute promyelocytic leukemias", European Journal of Histochemistry, 41(Suppl 2), 43-44.
21. Nagy, L., Thomazy, V.A., Shipley, G.L., Fesus, L., Lamph, W., Heyman, R.A., et al. (1995) "Activation of retinoid X receptors induces apoptosis in HL-60 cell lines", Molecular Cell Biology, 15, 3540-3551.
22. Kikuchi, H., Iizuka, R., Sugiyama, S., Gon, G., Mori, H., Arai, M., et al. (1996) "Monocytic differentiation modulates apoptotic response to cytotoxic anti-Fas antibody and tumor necrosis factor alpha in human monoblast U937 cells", Journal of Leukocyte Biology, 60, 778-783.
23. Salih, H.R., Starling, G.C., Brandl, S.F., Pelka-Fleischer, R., Haferlach, T., Hiddemann, W., et al. (2002) "Differentiation of promyelocytic leukaemia: alterations in Fas (CD95/Apo-1) and Fas ligand (CD178) expression", British Journal of Haematology, 117, 76-85.
24. Friesen, C., Herr, I., Krammer, P.H. and Debatin, K.M. (1996) "Involvement of the CD95 (APO-1 /FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells", Nature Medicine, 2, 574-577.
25. Eischen, C.M., Williams, B.L., Zhang, W., Samelson, L.E., Lynch, D.H., Abraham, R.T., et al. (1997) "ZAP-70 tyrosine kinase is required for the up-regulation of Fas ligand in activation-induced T cell apoptosis", Journal of Immunology, 159, 1135-1139.
26. Gamen, S., Anel, A., Lasierra, P., Alava, M.A., Martinez-Lorenzo, M.J., Pineiro, A., et al. (1997) "Doxorubicin-induced apoptosis in human T-cell leukemia is mediated by caspase-3 activation in a Fas-independent way", FEBS Letters, 417, 360-364.
27. Shibakura, M., Niiya, K., Kiguchi, T., Shinagawa, K., Ishimaru, F., Ikeda, K., et al. (2002) "Simultaneous induction of matrix metalloproteinase-9 and interleukin 8 by all-trans retinoic acid in human PL-21 and NB4 mycloid leukaemia cells", British Journal of Haematology, 118, 419-425.
28. Tanaka, M., Itai, T., Adachi, M. and Nagata, S. (1998) "Down-regulation of Fas ligand by shedding", Nature Medicine, 4, 31-36.
29. Schneider, P., Holler, N., Bodmer, J.L., Hahne, M., Frei, K., Fontana, A., et al. (1998) "Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with down-regulation of its proapoptotic activity and loss of liver toxicity", Journal of Experimental Medicine, 187, 1205-1213.
30. Salih, H.R., Starling, G.C., Knauff, M., Llewellyn, M.B., Davis, P.M., Pitts, W.J., et al. (2001) "Retinoic acid and vitamin E modulate expression and release of CD178 in carcinoma cells: consequences for induction of apoptosis in CD95-sensitive cells", Experimental Cell Research, 270, 248-258.
31. Yang, Y., Mercep, M., Ware, C.F. and Ashwell, J.D. (1995) "Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glueocorticoids", Journal of Experimental Medicine, 181, 1673-1682.
32. Bissonnette, R.P., Brunner, T., Lazarchik, S.B., Yoo, N.J., Boehm, M.F., Green, D.R., et al. (1995) "9-cis retinoic acid inhibition of activation-induced apoptosis is mediated via regulation of fas ligand and requires retinoic acid receptor and retinoid X receptor activation", Molecular Cell, 15, 5576-5585.
33. Muschen, M., Warskulat, U., Schmidt, B., Schulz, W.A. and Haussinger, D. (1998) "Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in human embryonal carcinoma cells by interferon gamma and all-trans retinoic acid", Biological Chemistry, 379, 1083-1091.
34. Buzyn, A., Petit, F., Ostankovitch, M., Figueiredo, S., Varet, B., Guillet, J.G., et al. (1999) "Membrane-bound Fas (Apo-1/CD95) ligand on leukemic cells: A mechanism of tumor immune escape in leukemia patients", Blood, 94, 3135-3140.
35. Igney, F.H., Behrens, C.K. and Krammer, P.H. (2000) "Tumor counterattack-concept and reality", European Journal of Immunology, 30, 725-731.
36. Restifo, N.P. (2000) "Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape", Nature Medicine, 6, 493-495.
37. Favre-Felix, N., Fromentin, A., Hammann, A., Solary, E., Martin, F. and Bonnotte, B. (2000) "Cutting edge: the tumor counterattack hypothesis revisited: colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway", Journal of Immunology, 164, 5023-5027.